Zafer Arık

798 total citations
57 papers, 476 citations indexed

About

Zafer Arık is a scholar working on Oncology, Reproductive Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zafer Arık has authored 57 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 14 papers in Reproductive Medicine and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zafer Arık's work include Ovarian cancer diagnosis and treatment (12 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Endometrial and Cervical Cancer Treatments (6 papers). Zafer Arık is often cited by papers focused on Ovarian cancer diagnosis and treatment (12 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Endometrial and Cervical Cancer Treatments (6 papers). Zafer Arık collaborates with scholars based in Türkiye, India and United States. Zafer Arık's co-authors include Neyran Kertmen, Kadri Altundağ, Taner Babacan, Mustafa Solak, Furkan Sarici, Özge Keskin, İbrahim Petekkaya, Fatma Paksoy Türköz, Sercan Aksoy and Yavuz Özışık and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Zafer Arık

46 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zafer Arık Türkiye 11 290 116 107 77 51 57 476
Daniel Murphy United States 4 177 0.6× 106 0.9× 126 1.2× 92 1.2× 32 0.6× 9 450
Ahmed A. Zeeneldin Egypt 16 266 0.9× 145 1.3× 121 1.1× 90 1.2× 59 1.2× 43 588
Marjory Charlot United States 13 319 1.1× 172 1.5× 119 1.1× 85 1.1× 52 1.0× 35 544
Frédérique Rousseau France 14 421 1.5× 120 1.0× 75 0.7× 156 2.0× 28 0.5× 60 744
Melina L Willson Australia 12 414 1.4× 186 1.6× 147 1.4× 148 1.9× 23 0.5× 21 732
Sana Al‐Sukhun United States 12 195 0.7× 75 0.6× 75 0.7× 79 1.0× 31 0.6× 31 451
Naoko Sasamoto United States 12 163 0.6× 67 0.6× 117 1.1× 55 0.7× 54 1.1× 56 725
Xiao‐Nan Tao China 12 200 0.7× 63 0.5× 133 1.2× 168 2.2× 86 1.7× 39 727
Șerban Negru Romania 11 118 0.4× 54 0.5× 97 0.9× 47 0.6× 33 0.6× 43 375
Marc Hilmi France 15 421 1.5× 128 1.1× 171 1.6× 123 1.6× 54 1.1× 34 716

Countries citing papers authored by Zafer Arık

Since Specialization
Citations

This map shows the geographic impact of Zafer Arık's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zafer Arık with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zafer Arık more than expected).

Fields of papers citing papers by Zafer Arık

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zafer Arık. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zafer Arık. The network helps show where Zafer Arık may publish in the future.

Co-authorship network of co-authors of Zafer Arık

This figure shows the co-authorship network connecting the top 25 collaborators of Zafer Arık. A scholar is included among the top collaborators of Zafer Arık based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zafer Arık. Zafer Arık is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yıldırım, Hasan Çağrı, et al.. (2025). Prognostic Impact of Pre-Treatment Modified Glasgow Prognostic Score (mGPS) on Survival in Patients with Advanced-Stage Ovarian Cancer. Journal of Clinical Medicine. 14(12). 4239–4239.
2.
3.
Şahin, Taha Koray, Deniz Can Güven, Zafer Arık, et al.. (2025). The association between blood sodium levels and survival in patients treated with immune checkpoint inhibitors. Expert Review of Molecular Diagnostics. 25(4). 129–137.
4.
5.
Karaçin, Cengiz, Zuhat Urakçı, Ali Yılmaz, et al.. (2024). Efficacy and Safety of Bevacizumab in Patients with Low-Grade Serous Ovarian Cancer. Future Oncology. 20(4). 207–214.
6.
Yıldırım, Hasan Çağrı, Deniz Ateş Özdemir, Deniz Can Güven, et al.. (2024). Effect of hypoxia-inducible factor-1 alpha expression on survival in patients with metastatic cervical squamous cell carcinoma treated with first-line chemotherapy and bevacizumab. SHILAP Revista de lepidopterología. 24(4). 998–1003. 1 indexed citations
7.
Sarı, Sezin Yüce, et al.. (2023). Leptomeningeal metastasis in primary uterine cervical cancer: a rare case and review of the literature. Oncology in Clinical Practice. 19(3). 184–189.
8.
Dizman, Gülçin Telli, Gökhan Metan, Pınar Zarakolu, et al.. (2023). Cessation of Rectal Screening for Vancomycin-Resistant Enterococci: Experience from a Tertiary Care Hospital from Türkiye. Healthcare. 11(19). 2641–2641. 2 indexed citations
9.
Güven, Deniz Can, et al.. (2023). KELIM Score Predicts Outcome in Patients with Platinum-Resistant/Refractory Recurrent Ovarian Cancer. Biomarkers in Medicine. 17(7). 379–389. 5 indexed citations
10.
Güven, Deniz Can, et al.. (2022). Retrospective comparison of flot and modified dcf as first-line chemotherapy in metastatic gastric adenocarcinoma. TURKISH JOURNAL OF MEDICAL SCIENCES. 52(5). 1559–1568. 2 indexed citations
11.
Güven, Deniz Can, Taha Koray Şahin, Oktay Halit Aktepe, et al.. (2021). Newly diagnosed cancer and the COVID-19 pandemic: tumour stage migration and higher early mortality. BMJ Supportive & Palliative Care. 14(e1). e456–e461. 28 indexed citations
12.
Güven, Deniz Can, Taha Koray Şahin, Oktay Halit Aktepe, et al.. (2021). Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapy. Supportive Care in Cancer. 29(9). 5417–5423. 15 indexed citations
13.
Aktepe, Oktay Halit, et al.. (2020). Lycopene sensitizes the cervical cancer cells to cisplatin via targeting nuclear factor- kappa B (NF-κB) pathway. TURKISH JOURNAL OF MEDICAL SCIENCES. 51(1). 368–374. 30 indexed citations
14.
Güven, Deniz Can, Taha Koray Şahin, Neyran Kertmen, et al.. (2020). COVID-19 pandemic: changes in cancer admissions. BMJ Supportive & Palliative Care. 14(e1). e376–e379. 26 indexed citations
15.
Gültekin, Melis, Ozan Cem Güler, Sezin Yüce Sarı, et al.. (2020). Multi-institutional validation of the ESMO-ESGO-ESTRO consensus conference risk grouping in Turkish endometrial cancer patients treated with comprehensive surgical staging. Journal of Obstetrics and Gynaecology. 41(3). 414–420. 7 indexed citations
16.
Güven, Deniz Can, Taha Koray Şahin, Neyran Kertmen, et al.. (2020). 1724P Changes in the outpatient and inpatient clinic admissions during COVID-19 pandemic: Anticipating and mitigating risks for cancer patients. Annals of Oncology. 31. S1011–S1011. 1 indexed citations
17.
Kertmen, Neyran, Taner Babacan, Özge Keskin, et al.. (2015). Molecular subtypes in patients with inflammatory breast cancer; a single center experience.. PubMed. 20(1). 35–9. 16 indexed citations
18.
Keskin, Özge, Sercan Aksoy, Taner Babacan, et al.. (2014). Impact of the obesity on lymph node status in operable breast cancer patients.. PubMed. 18(4). 824–30. 9 indexed citations
19.
Aksoy, Sercan, Mehmet Alı Nahıt Şendur, Zafer Arık, et al.. (2014). Variations in tumor marker levels in metastatic breast cancer patients according to tumor subtypes.. PubMed. 18(3). 608–13. 9 indexed citations
20.
Yazıcı, Ozan, Sercan Aksoy, Nuriye Özdemir, et al.. (2013). Arrhythmias during and after zoledronic acid infusion patients with bone metastasis. Medical Oncology. 30(3). 609–609. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Murphy Breakdown of academic impact, for papers by Ahmed A. Zeeneldin Breakdown of academic impact, for papers by Marjory Charlot Breakdown of academic impact, for papers by Frédérique Rousseau Breakdown of academic impact, for papers by Melina L Willson Breakdown of academic impact, for papers by Sana Al‐Sukhun Breakdown of academic impact, for papers by Naoko Sasamoto Breakdown of academic impact, for papers by Xiao‐Nan Tao Breakdown of academic impact, for papers by Șerban Negru Breakdown of academic impact, for papers by Marc Hilmi
Rankless by CCL
2026